Gay, Chloe
Guiguet-Auclair, Candy
Pereira, Bruno
Goldstein, Anna
Bareyre, Loïc
Coste, Nicolas
Coudeyre, Emmanuel
Funding for this research was provided by:
This work is financially supported by the “Innovatherm cluster” and “Clermont-Ferrand Communauté”. The “Auvergne region” for the “Cluster network research grant”
Article History
Received: 26 June 2017
Accepted: 27 September 2018
First Online: 16 October 2018
Ethics approval and consent to participate
: The study protocol was approved by the medical ethics committee of South-East France (Sud-Est 6), no. 2015/CE38, and was registered at ClinicalTrials.gov (NCT 02598804 on November 5, 2015. The trial will be conducted in compliance with both Good Clinical Practices and the Declaration of Helsinki. In accordance with French law, the ethics committee of South-East France (Sud-Est 6) and the study protocol, all patients will provide written consent to participate in the study after being informed in detail about the study procedures. The written consent will be reported in the medical file.
: No applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.